• ERT and Bioclinica are now Clario. Find out more about our new name, and why we have come together.

Your using an unsupported browser. Please update to a modern browser for a better experience.

Restart right, finish right

At Clario we partner with sponsors and Clinical Research Organizations (CROs) to get clinical trials back on track that other endpoint providers have struggled with. Our top priority is to deliver the accurate and compliant endpoint data for successful study completion, with the extra focus and urgency that rescue studies require. 

Our senior experts begin by understanding the specifics of each study, then apply their experience across protocol design, therapeutic areas, data and site management, and patient support. Through a collaborative process, specialists architect a scalable solution that considers all patient touchpoints while anticipating and mitigating any future risks.

The Clario difference

24/7

Sponsor & CRO Support

3,950

eCOA Studies

120+

Countries

Renew the eCOA endpoint solution in your study

From at-risk to rescued: Keep your clinical trial on track

Shadi Zoghi, Clario Vice President for Project Management, discusses some of the competencies that a technology partner should demonstrate during study setup to help ensure a successful launch or relaunch. A qualified endpoint provider offers a range of capabilities including a proven track record, scientific expertise, and project management rigor.

Dedicated Team

We assign a core team of a project manager, solution design associate, scientific advisor, and technical implementation manager from pre-award through completion.

Worldwide Coverage

Clario provides expert staffing, logistics and translations support around the globe.

Responsive

Senior resources based in Europe, North America, and Asia Pacific provide extended time zone coverage.

Methodical

Each study is managed with a playbook including a Current State Assessment and Customer Start-up Guidance.

Tailored

Solutions are adapted to the unique requirements of each study, utilizing proven best practices from prior experiences.

Regulatory Expertise

Clario has deep familiarity with the endpoint data standards of governing bodies in different countries.

Experienced

Our team of scientific experts has relevant experience in therapeutic areas, protocol design, site management, patient support, etc.

Seamless Transition

Data strategy and diary design are evaluated to recommend the best approach for transitioning eCOA endpoint vendors.

Woman in the wheelchair

We focus on your success

Our team of scientific and therapeutic experts work closely together on complex, time-critical studies. Our top priority is always delivering the accurate, precise, and compliant endpoint data for sponsors to complete trials successfully.

We have global reach

Clario can support multiple countries and thousands of patients – navigating regulations, shipping and logistics, and more. And our teams are prepared for the changes and fast-moving timelines associated with challenging trials.

Woman on a video call with a medical professional
Woman in meeting

We are your trusted partners

We anticipate possible obstacles and address every data, device, and delivery inquiry with customer stakeholders. Count on us for transparent and frequent communications about every dimension of the trial turnaround.

FAQ

We recommend a phased rollout to allow flexibility in adapting to experience gained with the initial sites and countries. The specifics of the deployment schedule will need to be planned carefully with the sponsor and/or Clinical Research Organization (CRO).

For a study that is underway with enrolled patients, we recommend that existing patients be switched to the Clario eCOA system at their next scheduled visit after the new system deployment. Clario does not encourage requiring a special visit for the purpose of transitioning to the new system.

Clario can use the inbound integration capabilities of our system, specifying our eCOA platform as an integration endpoint, ensuring that the required data is transferred accurately and efficiently. When a patient is initially set up in the Clario eCOA system, the eCOA device (handheld eDiary and/or Tablet) will automatically download the required historical data for that patient to the device.

Clario discourages sites from using paper backups to the eCOA system. Paper data is patient to increased variability and cannot meet the data defensibility requirements needed for endpoint data in support of a labeling claim. In addition, the use of paper requires documentation of the paper process and documenting training of stakeholders.

For effective transition to the Clario eCOA system, we assume the sponsor and/or CRO can provide the design specifications for the required reports to Clario.

All stakeholders must receive documented training on the Clario eCOA solution. Since the study is already active, it is unlikely that another set of in-person investigator meetings will be held to introduce the replacement eCOA system. Therefore, Clario recommends that site and patient training modules be made available on the eCOA devices themselves. This on-device functionality can be augmented by web-based training.

Our team of experts is available to address questions you may have about Clario eCOA Rescue Studies